Tag Archives: Zetia

Vytorin Settlements Result in $688M Payment for Investors

Merck & Co. has agreed to pay $688 million to settle a financial fraud lawsuit brought by investors, who alleged that the drug maker delayed the release of bad results from clinical trials that raised questions about the effectiveness of the blockbuster cholesterol drug Vytorin. …

Vytorin Cancer Link Not Seen by FDA

  • Written by: AboutLawsuits

Federal regulators indicate that it is unlikely that the cholesterol drug Vytorin causes cancer, despite a clinical study in 2008 which raised potential Vytorin cancer concerns.…

Zetia, Vytorin Problems Continue With Latest Study

  • Written by: AboutLawsuits

In the latest blow to popular cholesterol drugs Vytorin and Zetia, new research indicates that the medications may be less effective than older drugs in reducing the buildup of cholesterol in arteries, and were actually associated with more heart attacks and other heart-related incidents.…

Vytorin Class Action Lawsuits Mount as Justice Deptartment Investigates

  • Written by: AboutLawsuits

Merck & Co. and Schering-Plough Corp. currently face around 140 Vytorin class action lawsuits involving their once-popular cholesterol drug, which has been shown to provide no medical benefits over cheaper generic alternatives. In addition, this week the drug makers disclosed that the U.S. Department of Justice is now investigating their marketing of the medication.…

New Haven Connecticut Plans to File Vytorin Lawsuit

The city of New Haven, Connecticut, has indicated that they plan to file a Vytorin lawsuit against Merck and Schering-Plough to recover over $400,000 in prescription costs paid for employees who received the cholesterol drug that has been found to provide no medical benefit.…

Contact A Lawyer

Contact A Lawyer

Have A Potential Case Reviewed By An Attorney

  • This field is for validation purposes and should be left unchanged.